End-tidal sevoflurane and halothane concentrations during simulated airway occlusion in healthy humans

Anesthesiology

Volumn 111, Issue 2, 2009, Pages 287-292

  Talbot, Nick P ^a   Farmery, Andrew D ^b   Dorrington, Keith L ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE; SEVOFLURANE;

ADULT; AIRWAY OBSTRUCTION; ANESTHESIA INDUCTION; ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATION ANESTHESIA; MALE; MASS SPECTROMETRY; MINIMUM LUNG ALVEOLUS CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; REBREATHING; SIMULATION;

EID: 68249153441     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181ac1d7b     Document Type: Article

References (24)

1. Wang CY, Chiu CL, Delilkan AE: Sevoflurane for difficult intubation in children (Letter). Br J Anaesth 1998; 80:408
2. Barker I: Is sevoflurane replacing halothane? (letter). Br J Anaesth 1998; 80:123
3. Kandasamy R, Sivalingham P: Use of sevoflurane in difficult airways. Acta Anaesthesiol Scand 2000; 44:627-9
4. Mostafa SM, Atherton AM: Sevoflurane for difficult tracheal intubation. Br J Anaesth 1997; 79:392-3
5. Ip-Yam PC: Sevoflurane in acute airway obstruction (Letter). Br J Anaesth 1998; 80:273
6. Wodey E, Pladys P, Copin C, Lucas MM, Chaumont A, Carre P, Lelong B, Azzis O, Ecoffey C: Comparative hemodynamic depression of sevoflurane versus halothane in infants: An echocardiographic study. ANESTHESIOLOGY 1997; 87:795-800
7. Doi M, Ikeda K: Airway irritation produced by volatile anaesthetics during brief inhalation: Comparison of halothane, enflurane, isoflurane and sevoflurane. Can J Anaesth 1993; 40:122-6
8. Eger EI 2nd, Saidman LJ: Illustrations of inhaled anesthetic uptake, including intertissue diffusion to and from fat. Anesth Analg 2005; 100:1020-33
9. Black A, Sury MR, Hemington L, Howard R, Mackersie A, Hatch DJ: A comparison of the induction characteristics of sevoflurane and halothane in children. Anaesthesia 1996; 51:539-42
10. Lerman J, Davis PJ, Welborn LG, Orr RJ, Rabb M, Carpenter R, Motoyama E, Hannallah R, Haberkern CM: Induction, recovery, and safety characteristics of sevoflurane in children undergoing ambulatory surgery. A comparison with halothane. ANESTHESIOLOGY 1996; 84:1332-40
11. Fenlon S, Pearce A: Sevoflurane induction and difficult airway management (Letter). Anaesthesia 1997; 52:285-6
12. Ip-Yam PC: Sevoflurane for difficult tracheal intubation (Letter). Br J Anaesth 1998; 81:104
13. Girgis Y, Frerk CM, Pigott D: Redistribution of halothane and sevoflurane under simulated conditions of acute airway obstruction. Anaesthesia 2001; 56:613-5
14. Fragen RJ, Dunn KL: The minimum alveolar concentration (MAC) of sevoflurane with and without nitrous oxide in elderly versus young adults. J Clin Anesth 1996; 8:352-6
15. Miller RD, Wahrenbrock EA, Schroeder CF, Knipstein TW, Eger EI 2nd, Buechel DR: Ethylene- halothane anesthesia: Addition or synergism? ANESTHESIOLOGY 1969; 31:301-4
16. Sury MR, Black A, Hemington L, Howard R, Hatch DJ, Mackersie A: A comparison of the recovery characteristics of sevoflurane and halothane in children. Anaesthesia 1996; 51:543-6
17. Stern RC, Towler SC, White PF, Evers AS: Elimination kinetics of sevoflurane and halothane from blood, brain, and adipose tissue in the rat. Anesth Analg 1990; 71:658-64
18. Sawyer DC, Eger EI 2nd, Bahlman SH, Cullen BF, Impelman D: Concentration dependence of hepatic halothane metabolism. ANESTHESIOLOGY 1971; 34:230-5
19. Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED: Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther 1997; 281:400-11
20. Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, Tucker GT, Rostami-Hodjegan A: Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab 2007; 8:33-45
21. Chouker A, Martignoni A, Dugas M, Eisenmenger W, Schauer R, Kaufmann I, Schelling G, Lohe F, Jauch KW, Peter K, Thiel M: Estimation of liver size for liver transplantation: The impact of age and gender. Liver Transpl 2004; 10:678-85
22. Kharasch ED, Karol MD, Lanni C, Sawchuk R: Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics. ANESTHESIOLOGY 1995; 82:1369-78
23. Carpenter RL, Eger 2nd EI Johnson BH, Unadkat JD, Sheiner LB: The extent of metabolism of inhaled anesthetics in humans. ANESTHESIOLOGY 1986; 65:201-5
24. Yasuda N, Targ AG, Eger EI 2nd: Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 1989; 69:370-3